C. Oleg, “INFLUENCE OF A BIOLOGICALLY ACTIVE COMPOUND FROM SUBSTITUTED THIADIAZINES ON TRANSAMINASE ACTIVITY IN MYOCARDIAL HOMOGENATE IN EXPERIMENTAL MYOCARDIAL INFARCTION”, Int J Pharm Pharm Sci, vol. 7, no. 6, pp. 147–151, Jun. 2015.